CollPlant, Stratasys Explore 3D-Printed Breast Implants
CollPlant Biotechnologies and Stratasys Ltd. have initiated a pre-clinical study to develop 3D-printed regenerative breast implants that promote natural tissue growth and biodegrade over time.
CollPlant Biotechnologies and Stratasys Ltd. have initiated a pre-clinical study to develop 3D-printed regenerative breast implants that promote natural tissue growth and biodegrade over time.
Baldo Scassellati Sforzolini, MD, PhD, MBA, Galderma’s global head of research, recently presented data on RelabotulinumtoxinA, a six-month neuromodulator for wrinkles. The READY-4 trial confirms its safety and efficacy, supported by PEARL Technology across diverse groups. Here, Sforzolini shares his findings.